Budget Impact of the Vest™ High Frequency Chest Wall Oscillation System for Managing Airway Clearance in Patients with Complex Neurological ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-09-01

AUTHORS

Amir Ansaripour, Kari Roehrich, Atefeh Mashayekhi, Mwanamisi Wanjala, Shani Noel, Mohsen Rezaei Hemami, Angela Murray, Mehdi Javanbakht

ABSTRACT

ObjectiveAs a recognized therapy to improve airway clearance, high-frequency chest wall oscillation (HFCWO) is used to manage reduced vital capacity in patients with complex neuromuscular disorders (cNMD). This study aimed to investigate the budget impact of HFCWO versus chest wall physical therapy (CWPT) from a US-commercial payer perspective.MethodsIn combination with a previously developed cost-effectiveness model, a budget impact model was developed to evaluate the incremental budgetary impact associated with introducing a HFCWO device over a 5-year time horizon. The model compared the cost implications associated with the commonly used CWPT procedure, as the current scenario, with a new scenario consisting of 80% of market share for HFCWO. The resource use and costs included in the analyses were costs associated with the HFCWO device (Vest™ System) and its consumables, patient training, and medical services such as hospitalization, medications, emergency room, and outpatient visits. The primary outcome measures included total and incremental budgetary impact per member per year (PMPY).ResultsIn a hypothetical plan of 1,000,000 members (men: 49.2%), 2099 patients with cNMD were estimated to be eligible to receive airway clearance services over 5 years. The new scenario (HFCWO and CWPT [US$24 PMPY]) was cost-saving compared with the current scenario (CWPT only [$34 PMPY]) with a cost reduction of US$9.46 PMPY. The model estimated a net cost-saving of US$1,594,131 and US$9,591,343 over 1 and 5 years, respectively.ConclusionThis study suggests the HFCWO technique to manage the reduction in vital capacity in patients with cNMD would lead to favorable budget impact results. More... »

PAGES

1-10

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41669-021-00299-y

DOI

http://dx.doi.org/10.1007/s41669-021-00299-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1140806540

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34468966


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Optimax Access, Gustav Mahlerplein 2, 1082 MA, Amsterdam, The Netherlands", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Optimax Access, Gustav Mahlerplein 2, 1082 MA, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ansaripour", 
        "givenName": "Amir", 
        "id": "sg:person.014433631773.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014433631773.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hillrom, Saint Paul, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.453846.8", 
          "name": [
            "Hillrom, Saint Paul, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roehrich", 
        "givenName": "Kari", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Optimax Access, University of Southampton Science Park, Chilworth, Hampshire, UK", 
          "id": "http://www.grid.ac/institutes/grid.5491.9", 
          "name": [
            "Optimax Access, University of Southampton Science Park, Chilworth, Hampshire, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mashayekhi", 
        "givenName": "Atefeh", 
        "id": "sg:person.0634117476.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634117476.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hillrom, Saint Paul, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.453846.8", 
          "name": [
            "Hillrom, Saint Paul, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wanjala", 
        "givenName": "Mwanamisi", 
        "id": "sg:person.014402026051.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014402026051.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hillrom, Laurel, MD, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Hillrom, Laurel, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Noel", 
        "givenName": "Shani", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Aberdeen, Aberdeen, UK", 
          "id": "http://www.grid.ac/institutes/grid.7107.1", 
          "name": [
            "University of Aberdeen, Aberdeen, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hemami", 
        "givenName": "Mohsen Rezaei", 
        "id": "sg:person.01114255377.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114255377.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hillrom, Chicago, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.453846.8", 
          "name": [
            "Hillrom, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murray", 
        "givenName": "Angela", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Device Access, University of Southampton Science Park, Chilworth, Hampshire, UK", 
          "id": "http://www.grid.ac/institutes/grid.5491.9", 
          "name": [
            "Optimax Access, University of Southampton Science Park, Chilworth, Hampshire, UK", 
            "Device Access, University of Southampton Science Park, Chilworth, Hampshire, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Javanbakht", 
        "givenName": "Mehdi", 
        "id": "sg:person.01105552644.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105552644.92"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/s12883-019-1343-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1116652746", 
          "https://doi.org/10.1186/s12883-019-1343-1"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2021-09-01", 
    "datePublishedReg": "2021-09-01", 
    "description": "ObjectiveAs a recognized therapy to improve airway clearance, high-frequency chest wall oscillation (HFCWO) is used to manage reduced vital capacity in patients with complex neuromuscular disorders (cNMD). This study aimed to investigate the budget impact of HFCWO versus chest wall physical therapy (CWPT) from a US-commercial payer perspective.MethodsIn combination with a previously developed cost-effectiveness model, a budget impact model was developed to evaluate the incremental budgetary impact associated with introducing a HFCWO device over a 5-year time horizon. The model compared the cost implications associated with the commonly used CWPT procedure, as the current scenario, with a new scenario consisting of 80% of market share for HFCWO. The resource use and costs included in the analyses were costs associated with the HFCWO device (Vest\u2122 System) and its consumables, patient training, and medical services such as hospitalization, medications, emergency room, and outpatient visits. The primary outcome measures included total and incremental budgetary impact per member per year (PMPY).ResultsIn a hypothetical plan of 1,000,000 members (men: 49.2%), 2099 patients with cNMD were estimated to be eligible to receive airway clearance services over 5 years. The new scenario (HFCWO and CWPT [US$24 PMPY]) was cost-saving compared with the current scenario (CWPT only [$34 PMPY]) with a cost reduction of US$9.46 PMPY. The model estimated a net cost-saving of US$1,594,131 and US$9,591,343 over 1 and 5 years, respectively.ConclusionThis study suggests the HFCWO technique to manage the reduction in vital capacity in patients with cNMD would lead to favorable budget impact results.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41669-021-00299-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1284515", 
        "issn": [
          "2509-4262", 
          "2509-4254"
        ], 
        "name": "PharmacoEconomics - Open", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "high-frequency chest wall oscillation", 
      "complex neuromuscular disorder", 
      "airway clearance", 
      "vital capacity", 
      "budget impact", 
      "chest wall oscillation", 
      "primary outcome measure", 
      "US commercial payer perspective", 
      "US healthcare payers", 
      "budgetary impact", 
      "budget impact model", 
      "complex neurological disorder", 
      "cost-effectiveness model", 
      "outpatient visits", 
      "emergency room", 
      "physical therapy", 
      "payer perspective", 
      "outcome measures", 
      "patients", 
      "neuromuscular disorders", 
      "neurological disorders", 
      "healthcare payers", 
      "patient training", 
      "ConclusionThis study", 
      "medical services", 
      "therapy", 
      "clearance", 
      "disorders", 
      "cost implications", 
      "hypothetical plan", 
      "years", 
      "hospitalization", 
      "medications", 
      "resource use", 
      "visits", 
      "ObjectiveAs", 
      "payers", 
      "study", 
      "ResultsIn", 
      "reduction", 
      "wall oscillation", 
      "PMPY", 
      "vest", 
      "impact", 
      "current scenario", 
      "members", 
      "services", 
      "impact model", 
      "training", 
      "measures", 
      "room", 
      "procedure", 
      "analysis", 
      "capacity", 
      "use", 
      "combination", 
      "time horizon", 
      "model", 
      "plan", 
      "implications", 
      "results", 
      "consumables", 
      "cost", 
      "perspective analysis", 
      "new scenario", 
      "technique", 
      "devices", 
      "perspective", 
      "oscillation system", 
      "system", 
      "cost reduction", 
      "scenarios", 
      "impact results", 
      "oscillations", 
      "share", 
      "horizon", 
      "market share", 
      "chest wall physical therapy", 
      "wall physical therapy", 
      "MethodsIn combination", 
      "incremental budgetary impact", 
      "HFCWO device", 
      "CWPT procedure", 
      "airway clearance services", 
      "clearance services", 
      "HFCWO technique", 
      "favorable budget impact results", 
      "budget impact results", 
      "High Frequency Chest Wall Oscillation System", 
      "Frequency Chest Wall Oscillation System", 
      "Chest Wall Oscillation System", 
      "Wall Oscillation System", 
      "Managing Airway Clearance"
    ], 
    "name": "Budget Impact of the Vest\u2122 High Frequency Chest Wall Oscillation System for Managing Airway Clearance in Patients with Complex Neurological Disorders: A US Healthcare Payers\u2019 Perspective Analysis", 
    "pagination": "1-10", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1140806540"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41669-021-00299-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34468966"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41669-021-00299-y", 
      "https://app.dimensions.ai/details/publication/pub.1140806540"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_891.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41669-021-00299-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00299-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00299-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00299-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00299-y'


 

This table displays all metadata directly associated to this object as RDF triples.

214 TRIPLES      22 PREDICATES      118 URIs      109 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41669-021-00299-y schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N3e4488f1fc1f45e7b9ae7f11866bc94c
4 schema:citation sg:pub.10.1186/s12883-019-1343-1
5 schema:datePublished 2021-09-01
6 schema:datePublishedReg 2021-09-01
7 schema:description ObjectiveAs a recognized therapy to improve airway clearance, high-frequency chest wall oscillation (HFCWO) is used to manage reduced vital capacity in patients with complex neuromuscular disorders (cNMD). This study aimed to investigate the budget impact of HFCWO versus chest wall physical therapy (CWPT) from a US-commercial payer perspective.MethodsIn combination with a previously developed cost-effectiveness model, a budget impact model was developed to evaluate the incremental budgetary impact associated with introducing a HFCWO device over a 5-year time horizon. The model compared the cost implications associated with the commonly used CWPT procedure, as the current scenario, with a new scenario consisting of 80% of market share for HFCWO. The resource use and costs included in the analyses were costs associated with the HFCWO device (Vest™ System) and its consumables, patient training, and medical services such as hospitalization, medications, emergency room, and outpatient visits. The primary outcome measures included total and incremental budgetary impact per member per year (PMPY).ResultsIn a hypothetical plan of 1,000,000 members (men: 49.2%), 2099 patients with cNMD were estimated to be eligible to receive airway clearance services over 5 years. The new scenario (HFCWO and CWPT [US$24 PMPY]) was cost-saving compared with the current scenario (CWPT only [$34 PMPY]) with a cost reduction of US$9.46 PMPY. The model estimated a net cost-saving of US$1,594,131 and US$9,591,343 over 1 and 5 years, respectively.ConclusionThis study suggests the HFCWO technique to manage the reduction in vital capacity in patients with cNMD would lead to favorable budget impact results.
8 schema:genre article
9 schema:inLanguage en
10 schema:isAccessibleForFree true
11 schema:isPartOf sg:journal.1284515
12 schema:keywords CWPT procedure
13 Chest Wall Oscillation System
14 ConclusionThis study
15 Frequency Chest Wall Oscillation System
16 HFCWO device
17 HFCWO technique
18 High Frequency Chest Wall Oscillation System
19 Managing Airway Clearance
20 MethodsIn combination
21 ObjectiveAs
22 PMPY
23 ResultsIn
24 US commercial payer perspective
25 US healthcare payers
26 Wall Oscillation System
27 airway clearance
28 airway clearance services
29 analysis
30 budget impact
31 budget impact model
32 budget impact results
33 budgetary impact
34 capacity
35 chest wall oscillation
36 chest wall physical therapy
37 clearance
38 clearance services
39 combination
40 complex neurological disorder
41 complex neuromuscular disorder
42 consumables
43 cost
44 cost implications
45 cost reduction
46 cost-effectiveness model
47 current scenario
48 devices
49 disorders
50 emergency room
51 favorable budget impact results
52 healthcare payers
53 high-frequency chest wall oscillation
54 horizon
55 hospitalization
56 hypothetical plan
57 impact
58 impact model
59 impact results
60 implications
61 incremental budgetary impact
62 market share
63 measures
64 medical services
65 medications
66 members
67 model
68 neurological disorders
69 neuromuscular disorders
70 new scenario
71 oscillation system
72 oscillations
73 outcome measures
74 outpatient visits
75 patient training
76 patients
77 payer perspective
78 payers
79 perspective
80 perspective analysis
81 physical therapy
82 plan
83 primary outcome measure
84 procedure
85 reduction
86 resource use
87 results
88 room
89 scenarios
90 services
91 share
92 study
93 system
94 technique
95 therapy
96 time horizon
97 training
98 use
99 vest
100 visits
101 vital capacity
102 wall oscillation
103 wall physical therapy
104 years
105 schema:name Budget Impact of the Vest™ High Frequency Chest Wall Oscillation System for Managing Airway Clearance in Patients with Complex Neurological Disorders: A US Healthcare Payers’ Perspective Analysis
106 schema:pagination 1-10
107 schema:productId Ne59b774063194bc0840ea512d020cab1
108 Neb8a9be31c104f6f95cbd476a389b4e1
109 Nf88d62eb37fe4e819319909dc01fb8cc
110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1140806540
111 https://doi.org/10.1007/s41669-021-00299-y
112 schema:sdDatePublished 2022-01-01T19:01
113 schema:sdLicense https://scigraph.springernature.com/explorer/license/
114 schema:sdPublisher Nf67ca00e40fc4d5f98c6198418b7d83b
115 schema:url https://doi.org/10.1007/s41669-021-00299-y
116 sgo:license sg:explorer/license/
117 sgo:sdDataset articles
118 rdf:type schema:ScholarlyArticle
119 N012ea304c71b408db2ba76faeaf64499 rdf:first sg:person.01105552644.92
120 rdf:rest rdf:nil
121 N172d854c86c14f1b8a1282f4a6ea07fd rdf:first Na3aeac00fb3c4a8da5b3f81c649003a4
122 rdf:rest N012ea304c71b408db2ba76faeaf64499
123 N1d6de54fca3848c49bab3810fb994476 rdf:first sg:person.014402026051.70
124 rdf:rest N800b1470e6b94a6a846e6accdef50859
125 N3e4488f1fc1f45e7b9ae7f11866bc94c rdf:first sg:person.014433631773.32
126 rdf:rest N788fc8a19a5a4c1e98f5b82d2c85feae
127 N4d93afd0d8b44c34a4ae5df45c3eb36d rdf:first sg:person.0634117476.41
128 rdf:rest N1d6de54fca3848c49bab3810fb994476
129 N5006ec3773a04780b8588599b7d3f41b schema:affiliation grid-institutes:grid.453846.8
130 schema:familyName Roehrich
131 schema:givenName Kari
132 rdf:type schema:Person
133 N71878c761d1347aaa391303960003f24 rdf:first sg:person.01114255377.35
134 rdf:rest N172d854c86c14f1b8a1282f4a6ea07fd
135 N788fc8a19a5a4c1e98f5b82d2c85feae rdf:first N5006ec3773a04780b8588599b7d3f41b
136 rdf:rest N4d93afd0d8b44c34a4ae5df45c3eb36d
137 N800b1470e6b94a6a846e6accdef50859 rdf:first Nea983fb613884581a69d29692d50540d
138 rdf:rest N71878c761d1347aaa391303960003f24
139 Na3aeac00fb3c4a8da5b3f81c649003a4 schema:affiliation grid-institutes:grid.453846.8
140 schema:familyName Murray
141 schema:givenName Angela
142 rdf:type schema:Person
143 Ne59b774063194bc0840ea512d020cab1 schema:name doi
144 schema:value 10.1007/s41669-021-00299-y
145 rdf:type schema:PropertyValue
146 Nea983fb613884581a69d29692d50540d schema:affiliation grid-institutes:None
147 schema:familyName Noel
148 schema:givenName Shani
149 rdf:type schema:Person
150 Neb8a9be31c104f6f95cbd476a389b4e1 schema:name pubmed_id
151 schema:value 34468966
152 rdf:type schema:PropertyValue
153 Nf67ca00e40fc4d5f98c6198418b7d83b schema:name Springer Nature - SN SciGraph project
154 rdf:type schema:Organization
155 Nf88d62eb37fe4e819319909dc01fb8cc schema:name dimensions_id
156 schema:value pub.1140806540
157 rdf:type schema:PropertyValue
158 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
159 schema:name Medical and Health Sciences
160 rdf:type schema:DefinedTerm
161 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
162 schema:name Cardiorespiratory Medicine and Haematology
163 rdf:type schema:DefinedTerm
164 sg:journal.1284515 schema:issn 2509-4254
165 2509-4262
166 schema:name PharmacoEconomics - Open
167 schema:publisher Springer Nature
168 rdf:type schema:Periodical
169 sg:person.01105552644.92 schema:affiliation grid-institutes:grid.5491.9
170 schema:familyName Javanbakht
171 schema:givenName Mehdi
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105552644.92
173 rdf:type schema:Person
174 sg:person.01114255377.35 schema:affiliation grid-institutes:grid.7107.1
175 schema:familyName Hemami
176 schema:givenName Mohsen Rezaei
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114255377.35
178 rdf:type schema:Person
179 sg:person.014402026051.70 schema:affiliation grid-institutes:grid.453846.8
180 schema:familyName Wanjala
181 schema:givenName Mwanamisi
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014402026051.70
183 rdf:type schema:Person
184 sg:person.014433631773.32 schema:affiliation grid-institutes:None
185 schema:familyName Ansaripour
186 schema:givenName Amir
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014433631773.32
188 rdf:type schema:Person
189 sg:person.0634117476.41 schema:affiliation grid-institutes:grid.5491.9
190 schema:familyName Mashayekhi
191 schema:givenName Atefeh
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634117476.41
193 rdf:type schema:Person
194 sg:pub.10.1186/s12883-019-1343-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1116652746
195 https://doi.org/10.1186/s12883-019-1343-1
196 rdf:type schema:CreativeWork
197 grid-institutes:None schema:alternateName Hillrom, Laurel, MD, USA
198 Optimax Access, Gustav Mahlerplein 2, 1082 MA, Amsterdam, The Netherlands
199 schema:name Hillrom, Laurel, MD, USA
200 Optimax Access, Gustav Mahlerplein 2, 1082 MA, Amsterdam, The Netherlands
201 rdf:type schema:Organization
202 grid-institutes:grid.453846.8 schema:alternateName Hillrom, Chicago, IL, USA
203 Hillrom, Saint Paul, MN, USA
204 schema:name Hillrom, Chicago, IL, USA
205 Hillrom, Saint Paul, MN, USA
206 rdf:type schema:Organization
207 grid-institutes:grid.5491.9 schema:alternateName Device Access, University of Southampton Science Park, Chilworth, Hampshire, UK
208 Optimax Access, University of Southampton Science Park, Chilworth, Hampshire, UK
209 schema:name Device Access, University of Southampton Science Park, Chilworth, Hampshire, UK
210 Optimax Access, University of Southampton Science Park, Chilworth, Hampshire, UK
211 rdf:type schema:Organization
212 grid-institutes:grid.7107.1 schema:alternateName University of Aberdeen, Aberdeen, UK
213 schema:name University of Aberdeen, Aberdeen, UK
214 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...